Navigation Links
Boston Scientific Statement on the Passing of Senator Edward Kennedy
Date:8/26/2009

NATICK, Mass., Aug. 26 /PRNewswire/ --

The statement below is from Pete Nicholas, Chairman of the Board of Boston Scientific Corporation, on behalf of the Company, its employees and its Board of Directors.

Senator Kennedy leaves a legacy of unprecedented accomplishment across a remarkably broad spectrum of issues. Foremost among them was his long and productive work on health care, a cause we shared with him.

He was a tireless advocate for patients' rights and for access to quality health care for all. Over the past half century, he was involved in the passage of virtually every piece of major health care legislation, from Medicare in the 1960s to the recent children's health insurance bill.

We were fortunate to have Senator Kennedy visit our facilities to learn about our products and technologies and to thank our employees for all they do to improve patients' lives.

We are profoundly grateful for the opportunity to have known him, to have worked with him and to have been inspired by him.

Our tribute - and pledge - to Senator Kennedy is to continue working relentlessly on behalf of patients, many of whom saw him as their most dedicated champion and for whom medical innovation offers the greatest hope for restored health.

We will miss Senator Kennedy very much.

We extend our deepest sympathies to his family.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

    CONTACT: Paul Donovan
             508-650-8541 (office)
             508-667-5165 (mobile)
             Media Relations
             Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT-CRT Trial
2. Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology
3. Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
4. Boston Scientific to Participate in Wachovia Conference
5. Boston Scientifics SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)
6. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
7. FDA Approves Boston Scientifics Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
8. Angiotechs corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent
9. Boston Scientific Welcomes Launch of Syntax Score Website
10. Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Childrens Hospital Boston and Massachusetts General Hospital
11. Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Diego, CA (PRWEB) , ... ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically ... all bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... ... , ... Disappearing forests and increased emissions are the main causes of the ... Especially those living in larger cities are affected by air pollution related diseases. , ... pollution-affected countries globally - decided to take action. , “I knew I had to ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
(Date:3/24/2017)... 2017 The Controller General of Immigration from Maldives ... Algeen have received the prestigious international IAIR Award for the most ... Reading ... Maldives ... Abdulla Algeen (small picture on the right) have received the IAIR award ...
Breaking Biology News(10 mins):